Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation

Elevated levels of erythropoietin (EPO) are associated with an increased risk of death in renal transplant recipients (RTRs), but the underlying mechanisms remain unclear. Emerging data suggest that EPO stimulates production of the phosphaturic hormone fibroblast growth factor 23 (FGF23), another st...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenga, Michele F., De Jong, Maarten A., Leaf, David E., Nolte, Ilja M., De Borst, Martin H., Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356141/
https://www.ncbi.nlm.nih.gov/pubmed/32512806
http://dx.doi.org/10.3390/jcm9061737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356141/
https://www.ncbi.nlm.nih.gov/pubmed/32512806
http://dx.doi.org/10.3390/jcm9061737

Ejemplares similares